Pituitary Neoplasms
14
1
3
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
2 terminated out of 14 trials
66.7%
-19.8% vs benchmark
21%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)
Long Term Outcome Study in Patients With Pituitary Disorders
Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
Analgesia Nociception Index (ANI) in Intracranial Surgical Anesthesia
Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection
Radiomic and Pathomic Study of Pituitary Adenoma Using Machine Learning
Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland
Intraoperative Imaging of Pituitary Adenomas by OTL
Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions